946 related articles for article (PubMed ID: 11253736)
1. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction.
Rallidis LS; Megalou AA; Papageorgakis NH; Trikas AG; Chatzidimitriou GI; Tsitouris GK
Thromb Haemost; 1996 Sep; 76(3):417-21. PubMed ID: 8883280
[TBL] [Abstract][Full Text] [Related]
3. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
7. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
[TBL] [Abstract][Full Text] [Related]
8. Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction.
Lundblad D; Dinesen B; Rautio A; Røder ME; Eliasson M
J Intern Med; 2005 Jul; 258(1):13-20. PubMed ID: 15953128
[TBL] [Abstract][Full Text] [Related]
9. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324
[TBL] [Abstract][Full Text] [Related]
10. Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease.
Kohler HP; Carter AM; Stickland MH; Grant PJ
Thromb Haemost; 1998 Jan; 79(1):14-8. PubMed ID: 9459314
[TBL] [Abstract][Full Text] [Related]
11. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
[TBL] [Abstract][Full Text] [Related]
12. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
Appel SJ; Harrell JS; Davenport ML
J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
[TBL] [Abstract][Full Text] [Related]
13. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
15. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men.
Muscari A; Massarelli G; Bastagli L; Poggiopollini G; Tomassetti V; Drago G; Martignani C; Pacilli P; Boni P; Puddu P
Eur Heart J; 2000 Jul; 21(13):1081-90. PubMed ID: 10843826
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in the determinants of fibrinolytic activity.
MacCallum PK; Cooper JA; Howarth DJ; Meade TW; Miller GJ
Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046
[TBL] [Abstract][Full Text] [Related]
17. Small, dense LDL particle concentration correlates with plasminogen activator inhibitor type-1 (PAI-1) activity.
Väisänen S; Baumstark MW; Penttilä I; Bouchard C; Halonen P; Rankinen T; Berg A; Rauramaa R
Thromb Haemost; 1997 Dec; 78(6):1495-9. PubMed ID: 9423801
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
Herlihy OM; Barrow BA; Grant PJ; Levy JC
Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
[TBL] [Abstract][Full Text] [Related]
19. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome.
Ragab A; Abousamra NK; Higazy A; Saleh O
Lab Hematol; 2008; 14(1):1-6. PubMed ID: 18403313
[TBL] [Abstract][Full Text] [Related]
20. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]